157 related articles for article (PubMed ID: 18940664)
1. Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor.
Eelen G; Valle N; Sato Y; Rochel N; Verlinden L; De Clercq P; Moras D; Bouillon R; Muñoz A; Verstuyf A
Chem Biol; 2008 Oct; 15(10):1029-34. PubMed ID: 18940664
[TBL] [Abstract][Full Text] [Related]
2. CD-ring modified vitamin D3 analogs and their superagonistic action.
Eelen G; Verlinden L; Bouillon R; De Clercq P; Muñoz A; Verstuyf A
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):417-9. PubMed ID: 20132886
[TBL] [Abstract][Full Text] [Related]
3. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
[TBL] [Abstract][Full Text] [Related]
4. Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide.
Vanhooke JL; Benning MM; Bauer CB; Pike JW; DeLuca HF
Biochemistry; 2004 Apr; 43(14):4101-10. PubMed ID: 15065852
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and structure-activity relationships of 16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs having side chains of different sizes.
Takaku H; Miyamoto Y; Asami S; Shimazaki M; Yamada S; Yamamoto K; Udagawa N; DeLuca HF; Shimizu M
Bioorg Med Chem; 2008 Feb; 16(4):1796-815. PubMed ID: 18032055
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals.
Xu H; McCann M; Zhang Z; Posner GH; Bingham V; El-Tanani M; Campbell FC
Mol Carcinog; 2009 Aug; 48(8):758-72. PubMed ID: 19184984
[TBL] [Abstract][Full Text] [Related]
7. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3.
Pendás-Franco N; García JM; Peña C; Valle N; Pálmer HG; Heinäniemi M; Carlberg C; Jiménez B; Bonilla F; Muñoz A; González-Sancho JM
Oncogene; 2008 Jul; 27(32):4467-77. PubMed ID: 18408752
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators.
Inaba Y; Yamamoto K; Yoshimoto N; Matsunawa M; Uno S; Yamada S; Makishima M
Mol Pharmacol; 2007 May; 71(5):1298-311. PubMed ID: 17325131
[TBL] [Abstract][Full Text] [Related]
9. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model.
Mizwicki MT; Bishop JE; Norman AW
Steroids; 2005; 70(5-7):464-71. PubMed ID: 15862832
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D analogs and coactivators.
Eelen G; Verlinden L; De Clercq P; Vandewalle M; Bouillon R; Verstuyf A
Anticancer Res; 2006; 26(4A):2717-21. PubMed ID: 16886682
[TBL] [Abstract][Full Text] [Related]
11. Potent antagonist for the vitamin D receptor: vitamin D analogues with simple side chain structure.
Sakamaki Y; Inaba Y; Yoshimoto N; Yamamoto K
J Med Chem; 2010 Aug; 53(15):5813-26. PubMed ID: 20608741
[TBL] [Abstract][Full Text] [Related]
12. Fluorinated vitamin D analogs to probe the conformation of vitamin D in its receptor complex: 19F-NMR studies and biological activity.
Ohno A; Shimizu M; Yamada S
Chem Pharm Bull (Tokyo); 2002 Apr; 50(4):475-83. PubMed ID: 11963993
[TBL] [Abstract][Full Text] [Related]
13. Effects of fluorines on nonsecosteroidal vitamin D receptor agonists.
Kashiwagi H; Ohta M; Ono Y; Morikami K; Itoh S; Sato H; Takahashi T
Bioorg Med Chem; 2013 Feb; 21(3):712-21. PubMed ID: 23266184
[TBL] [Abstract][Full Text] [Related]
14. 2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
Shimizu M; Miyamoto Y; Takaku H; Matsuo M; Nakabayashi M; Masuno H; Udagawa N; DeLuca HF; Ikura T; Ito N
Bioorg Med Chem; 2008 Jul; 16(14):6949-64. PubMed ID: 18539034
[TBL] [Abstract][Full Text] [Related]
15. Model of three-dimensional structure of VDR bound with Vitamin D3 analogs substituted at carbon-2.
Sicinska W; Rotkiewicz P; DeLuca HF
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):107-10. PubMed ID: 15225755
[TBL] [Abstract][Full Text] [Related]
16. 19F NMR study on the complex of fluorinated vitamin D derivatives with vitamin D receptor: elucidation of the conformation of vitamin D ligands accommodated in the receptor.
Morizono D
J Med Dent Sci; 2011 Dec; 58(4):103-12. PubMed ID: 23896933
[TBL] [Abstract][Full Text] [Related]
17. 1α,25(OH)2-3-epi-vitamin D3, a natural physiological metabolite of vitamin D3: its synthesis, biological activity and crystal structure with its receptor.
Molnár F; Sigüeiro R; Sato Y; Araujo C; Schuster I; Antony P; Peluso J; Muller C; Mouriño A; Moras D; Rochel N
PLoS One; 2011 Mar; 6(3):e18124. PubMed ID: 21483824
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism.
Nakabayashi M; Yamada S; Yoshimoto N; Tanaka T; Igarashi M; Ikura T; Ito N; Makishima M; Tokiwa H; DeLuca HF; Shimizu M
J Med Chem; 2008 Sep; 51(17):5320-9. PubMed ID: 18710208
[TBL] [Abstract][Full Text] [Related]
19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
20. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
